ANI Pharmaceuticals reported $3.06M in Interest Expense on Debt for its fiscal quarter ending in September of 2026.





Interest Expense On Debt Change Date
AbbVie USD 688M 58M Sep/2026
ANI Pharmaceuticals USD 3.06M 580K Sep/2026
Aurora Cannabis CAD 464K 234K Jun/2026
Canopy Growth CAD 12.68M 364K Jun/2026
Eli Lilly USD 316M 201.3M Sep/2026
Heron Therapeutics USD 600K 100K Dec/2024
Hikma Pharmaceutical USD 67M 47M Dec/2025
Knight Therapeutics CAD 3.92M 1.56M Dec/2025
Nektar Therapeutics USD 7.94M 1.83M Mar/2026
Novartis USD 281M 8M Sep/2025
Omeros USD 4.05M 5.16M Sep/2024
Perrigo USD 7.48B 124.6M Sep/2026
Sun Pharmaceuticals INR 859M 139.6M Mar/2026
Teva Pharmaceutical Industries USD 414M 219M Sep/2026